Journal of Antimicrobial Chemotherapy (2000) 46, 411-422
© 2000 The British Society for Antimicrobial Chemotherapy
Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribing
a Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT; b IMS-HEALTH UK, 107 Marsh Road, Pinner, Middlesex HA5 5HQ; c Public Health Laboratory Service Headquarters, 61 Colindale Avenue, London NW9 5HT, UK
Over 200 hospitals in England report resistance data for bacteraemia and meningitis isolates to the Public Health Laboratory Service. We reviewed ampicillin and trimethoprim resistance rates from 1990 to 1997 for Escherichia coli, which is the species reported most frequently from these bacteraemias. Ampicillin resistance was relatively stable over time, but varied between Health Regions. The proportion of ampicillin-resistant E. coli in the East Anglia region remained 
42% in all years except one and that in the South Western region always remained <50%. At the other extreme, the proportions of ampicillin-resistant isolates in the Northern and Trent regions never fell below 59%. The prevalence of resistance to trimethoprim rose over time in most regions; again, however, the prevalence of resistant isolates was lowest in the East Anglia and South Western regions, whereas the highest resistance rates were reported from Mersey, NW Thames, NE Thames and North Western regions. These observations were related to data for community prescribing, which accounts for most ampicillin and trimethoprim use. Prescribing data for ampicillin and trimethoprim from 1987 to 1997 were obtained from the IMS-HEALTH Medical Data Index, and data for all antibacterial drugs between 1995 and 1997 from the Prescription Pricing Authority. Correlations between resistance rates and prescribing of specific antibiotics were weak, although there was some trend for regions with high total prescribing to have higher rates of ampicillin resistance. The South Western region was conspicuous both for low rates of resistance and low prescribing. Several factors may determine the lack of wider and more obvious relationships between resistance and prescribing. In particular, regions may be inappropriately large areas to test the relationship, isolates from bacteraemias may not be representative of those experiencing selection pressure in the community and the resistance data may have been distorted by nosocomial strains, although this seems unlikely with E. coli.
* Correspondence address. Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK. Tel: +44-20-8200-4400; Fax: +44-20-8200-7449; E-mail: DLivermore{at}phls.nhs.uk
Retired.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Bergman, S. T. Nyberg, P. Huovinen, P. Paakkari, A. J. Hakanen, and and the Finnish Study Group for Antimicrobial Resi Association between Antimicrobial Consumption and Resistance in Escherichia coli Antimicrob. Agents Chemother., March 1, 2009; 53(3): 912 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Reeves The 2005 Garrod Lecture: The changing access of patients to antibiotics - for better or worse? J. Antimicrob. Chemother., March 1, 2007; 59(3): 333 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Uzunovic-Kamberovic Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina J. Antimicrob. Chemother., August 1, 2006; 58(2): 344 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. V. Kern, M. Steib-Bauert, K. de With, S. Reuter, H. Bertz, U. Frank, and H. von Baum Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999-2002 J. Antimicrob. Chemother., January 1, 2005; 55(1): 57 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kahlmeter, P. Menday, and O. Cars Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection J. Antimicrob. Chemother., December 1, 2003; 52(6): 1005 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. I. F. Batchelor, D. W. M. Crook, T. Jones, and I. C. J. W. Bowler Impact of guidelines for the diagnosis of urinary tract infection on trimethoprim susceptibility of Escherichia coli J. Antimicrob. Chemother., January 1, 2002; 49(1): 223 - 224. [Full Text] [PDF]
|
|